Exploratory activity, motor coordination, and spatial learning in Mchr1 knockout mice

Behavioural Brain Research

Volumn 178, Issue 2, 2007, Pages 293-304

  Lalonde, R ^a,b   Qian, S ^c  

^a UNIVERSITÉ DE ROUEN   (France)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anxiety; Melanin concentrating hormone receptor 1; Motor activity; SHIRPA; Spatial learning

Indexed keywords

GENE PRODUCT; MELANIN CONCENTRATING HORMONE RECEPTOR 1; UNCLASSIFIED DRUG;

ACTIMETRY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; KNOCKOUT MOUSE; LATENT PERIOD; LEARNING; MALE; MAZE TEST; MCHR1 GENE; MOTOR COORDINATION; MOUSE; MOUSE STRAIN; MUTANT; MUTATION; NONHUMAN; PRIORITY JOURNAL; VOCALIZATION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; EXPLORATORY BEHAVIOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, SOMATOSTATIN; ROTAROD PERFORMANCE TEST; SPECIES SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 33847667912     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.01.006     Document Type: Article

References (73)

1. Adamantidis A., Thomas E., Foidart A., Tyhon A., Coumans B., Minet A., et al. Disrupting the melanin-concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function. Eur J Neurosci 21 (2005) 2837-2844
2. Adan R.A., and Gispen W.H. Melanocortins and the brain: from effects via receptors to drug targets. Eur J Pharmacol 405 (2000) 13-24
3. Adan R.A., and Vink T. Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders. Eur Neuropsychopharmacol 11 (2001) 483-490
4. An S., Cutler G., Zhao J.J., Huang S.G., Tian H., Li W., et al. Identification and characterization of a melanin-concentrating hormone receptor. Proc Natl Acad Sci USA 98 (2001) 7576-7581
5. Astrand A., Bohlooly Y.M., Larsdotter S., Mahlapuu M., Andersen H., Tornell J., et al. Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am J Physiol Regul Integr Comp Physiol 287 (2004) R749-R758
6. Balogh S.A., McDowell C.S., Stavnezer A.J., and Denenberg V.H. A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL/6J mice. Brain Res 836 (1999) 38-48
7. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868 (2000) 79-87
8. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319 (1992) 218-245
9. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8 (2002) 825-830
10. Boutin J.A., Suply T., Audinot V., Rodriguez M., Beauverger P., Nicolas J.P., et al. Melanin-concentrating hormone and its receptors: state of the art. Can J Physiol Pharmacol 80 (2002) 388-395
11. Broberger C., and Hokfelt T. Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav 74 (2001) 669-682
12. Burdyga G., Varro A., Dimaline R., Thompson D.G., and Dockray G.J. Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones. Neuroscience 137 (2006) 1405-1415
13. Burne T.H., McGrath J.J., Eyles D.W., and Mackay-Sim A. Behavioural characterization of Vitamin D receptor knockout mice. Behav Brain Res 157 (2005) 299-308
14. Butler A.A., Marks D.L., Fan W., Kuhn C.M., Bartolome M., and Cone R.D. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 4 (2001) 605-611
15. Chaffer C.L., and Morris M.J. The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat. Endocrinology 143 (2002) 191-197
16. Chaki S., Funakoshi T., Hirota-Okuno S., Nishiguchi M., Shimazaki T., Iijima M., et al. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther 313 (2005) 831-839
17. 3-36. Proc Natl Acad Sci USA 101 (2004) 4695-4700
18. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145 (2004) 2607-2612
19. Chen Y., Hu C., Hsu C.K., Zhang Q., Bi C., Asnicar M., et al. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143 (2002) 2469-2477
20. Contet C., Rawlins J.N., and Bannerman D.M. Faster is not surer-a comparison of C57BL/6J and 129S2/Sv mouse strains in the water maze. Behav Brain Res 125 (2001) 261-267
21. Contet C., Rawlins J.N., and Deacon R.M. A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res 124 (2001) 33-46
22. Costentin J. Éléments de physiologie et de neurobiologie de la prise alimentaire. Ann Pharm Fr 62 (2004) 92-102
23. Elliott J.C., Harrold J.A., Brodin P., Enquist K., Backman A., Bystrom M., et al. Increases in melanin-concentrating hormone and MCH receptor levels in the hypothalamus of dietary-obese rats. Mol Brain Res 128 (2004) 150-159
24. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
25. Hatcher J.P., Jones D.N.C., Rogers D.C., Hatcher P.D., Reavill C., Hagan J.J., et al. Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 125 (2001) 43-47
26. Hervieu G.J., Cluderay J.E., Harrison D., Meakin J., Maycox P., Nasir S., et al. The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur J Neurosci 12 (2000) 1194-1216
27. Holmes A. Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci Biobehav Rev 25 (2001) 261-273
28. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23 (1999) 971-980
29. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
30. Kaasinen S.K., Oksman M., Alhonen L., Tanila H., and Janne J. Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol Biochem Behav 78 (2004) 35-45
31. Kela J., Salmi P., Rimondini-Giorgini R., Heilig M., and Wahlestedt C. Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept 114 (2003) 109-114
32. Kokkotou E.G., Tritos N.A., Mastaitis J.W., Slieker L., and Maratos-Flier E. Melanin-concentrating hormone receptor is a target of leptin action in the mouse brain. Endocrinology 142 (2001) 680-686
33. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 26 (2002) 91-104
34. Lalonde R., Dumont M., Staufenbiel M., and Strazielle C. Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res 157 (2005) 91-98
35. Lalonde R., Eyer J., Wunderle V., and Strazielle C. Characterization of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor function. Behav Proc 63 (2003) 9-19
36. Lalonde R., Dumont M., Paly E., London J., and Strazielle C. Characterization of hemizygous SOD1/wild-type transgenic mice with the SHIRPA primary screen and tests of sensorimotor function and anxiety. Brain Res Bull 64 (2004) 251-258
37. Ludwig D.S., Mountjoy K.G., Tatro J.B., Gillette J.A., Frederich R.C., Flier J.S., et al. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 274 (1998) E627-E633
38. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J., et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107 (2001) 379-386
39. Marsh D.J., Weingarth D.T., Novi D.E., Chen H.Y., Trumbauer M.E., Chen A.S., et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99 (2002) 3240-3245
40. Miller C.L., Hruby V.J., Matsunaga T.O., and Bickford P.C. Alpha-MSH and MCH are functional antagonists in a CNS auditory gating paradigm. Peptides 14 (1993) 431-440
41. Miner L.L. Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol Biochem Behav 58 (1997) 25-30
42. Monzon M.E., and De Barioglio S.R. Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats. Physiol Behav 67 (1999) 813-817
43. Monzon M.E., Varas M.M., and De Barioglio S.R. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 22 (2001) 1043-1047
44. Monzon M.E., de Souza M.M., Izquierdo L.A., Izquierdo I., Barros D.M., and de Barioglio S.R. Melanin-concentrating hormone (MCH) modifies memory retention in rats. Peptides 20 (1999) 1517-1519
45. Morris R.G.M., Garrud P., Rawlins J.N.P., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 292 (1982) 681-683
46. Mystkowski P., Seeley R.J., Hahn T.M., Baskin D.G., Havel P.J., Matsumoto A.M., et al. Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss. J Neurosci 20 (2000) 8637-8642
47. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 (1997) 135-138
48. Qian S., Chen H., Weingarth D., Trumbauer M.E., Novi D.E., Guan X., et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22 (2002) 5027-5035
49. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380 (1996) 243-247
50. mdx3cv dystrophin-deficient mice. Mamm Genome 11 (2000) 725-728
51. Rees J.L. The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res 13 (2000) 135-140
52. Rogers D.C., Jones D.N.C., Nelson P.R., Jones C.M., Quilter C.A., Robinson T.L., et al. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105 (1999) 207-217
53. Roseberry A.G., Liu H., Jackson A.C., Cai X., and Friedman J.M. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41 (2004) 711-722
54. Roy M., David N.K., Danao J.V., Baribault H., Tian H., and Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 31 (2006) 112-120
55. Segal-Lieberman G., Bradley R.L., Kokkotou E., Carlson M., Trombly D.J., Wang X., et al. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA 100 (2003) 10085-10090
56. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396 (1998) 670-674
57. Shimokawa T., Kumar M.V., and Lane M.D. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc Natl Acad Sci USA 99 (2002) 66-71
58. Smith D.G., Davis R., Rorick-Kehn L., Morin M., Witkin J.M., McKinzie D.L., et al. Melanin-concentrating hormone-1 receptor modulated neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31 (2005) 1135-1145
59. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25 (2005) 914-922
60. Ste Marie L., Miura G.I., Marsh D.J., Yagaloff K., and Palmiter R.D. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 97 (2000) 12339-12344
61. Tan C.P., Sano H., Iwaasa H., Pan J., Sailer A.W., Hreniuk D.L., et al. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79 (2002) 785-792
62. Toumaniantz G., Ferreira P.C., Allaeys I., Bittencourt J.C., and Nahon J.L. Differential neuronal expression and projections of melanin-concentrating hormone (MCH) and MCH-gene-overprinted-polypeptide (MGOP) in the rat brain. Eur J Neurosci 12 (2000) 4367-4380
63. Tritos N.A., Mastaitis J.W., Kokkotou E., and Maratos-Flier E. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res 895 (2001) 160-166
64. Vergoni A.V., and Bertolini A. Role of melanocortins in the central control of feeding. Eur J Pharmacol 405 (2000) 25-32
65. Verlaeten O., Griffond B., Khuth S.T., Giraudon P., Akaoka H., Belin M.F., et al. Down regulation of melanin concentrating hormone in virally induced obesity. Mol Cell Endocrinol 181 (2001) 207-219
66. Voikar V., Koks S., Vasar E., and Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72 (2001) 271-281
67. Wang S., Behan J., O'Neill K., Weig B., Fried S., Laz T., et al. Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, mch-r2. J Biol Chem 276 (2001) 34664-34670
68. Weide K., Christ N., Moar K.M., Arens J., Hinney A., Mercer J.G., et al. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiol Genom 13 (2003) 47-56
69. Wolff M., Savova M., Malleret G., Segu L., and Buhot M.C. Differential learning abilities of 129T2/Sv and C57BL/6J mice as assessed in three water maze protocols. Behav Brain Res 136 (2002) 463-474
70. Yaswen L., Diehl N., Brennan M.B., and Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5 (1999) 1066-1070
71. Zheng H., Patterson M., Morrison C., Banfield B.W., Randall J.A., Browning K.N., et al. Melanin concentrating hormone innervation of caudal brainstem areas involved in gastrointestinal function and energy balance. Neuroscience 135 (2005) 611-625
72. Zheng Q.Y., Johnson K.R., and Erway L.C. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130 (1999) 94-107
73. Zhou D., Shen Z., Strack A., Marsh D.J., and Shearmann L.P. Enhanced running wheel activity of both Mchr1 and Pmch-deficient mice. Regul Pept 124 (2005) 53-63